Desjardins Insurance and OncoHelix are Empowering Cancer Patients with Access to Genomic Profiling
OncoHelix is collaborating with Desjardins Insurance to increase access to genomic profiling for cancer patients across Canada. As part of Desjardins Insurance’s Cancer Care Focus initiative, this collaboration aims to make advanced cancer diagnostics more accessible to group insurance plan members and their dependents.
Cancer affects each person differently, making every journey deeply personal. Understanding the DNA of your tumour can bring you one step closer to answers you need.
Cancer genomic profiling, more commonly known as biomarker testing, helps identify genetic mutations and alterations that may be driving your cancer. These insights can guide your care team in choosing the most effective treatment options for you, avoiding unnecessary treatments, and even opening opportunities for clinical trials.
Why Test With OncoHelix?
OncoHelix provides best-in-class tumor profiling at our clinically accredited lab. We offer options for analysis of either tissue biopsy or liquid biopsy through a convenient blood draw. Rest assured, your sample and personal health data remain secure and protected in Canada. Consult your healthcare provider to determine the most appropriate choice for you.
For questions about testing and ordering, please reach out to us here or contact OncoHelix at 1-800-410-4737, available Monday to Friday, 10 AM to 7 PM ET.
Unlock Benefits with Desjardins Insurance
As a Desjardins group insurance plan member, you and your dependents can access these tests through OncoHelix at a 10% discount. When ordering a test, plan members will be requested to provide their group and certificate numbers to get the discount.
If you have questions about whether laboratory tests are covered under your group plan, please refer to your insurance booklet or call the Desjardins Insurance Client Relations Centre at 1-800-463-7843, available Monday to Friday, 8 AM to 8 PM ET. Please note that Desjardins Insurance will neither have access to the test results nor be able to identify the individuals who submitted a request.
Desjardins' Cancer Care Focus initiative gives group insurance plan members access to OncoHelix’s cancer testing portfolio.
To order a test, you will need a completed and signed requisition form from your physician or healthcare practitioner. Our cancer laboratory tests aid in cancer diagnosis, help classify cancer risk, and assist in identifying targeted therapies. Get testing that is as unique as your cancer — because your path to treatment deserves precision.
This discount is also available across our broader testing menu, which include
Pharmacogenomics (PGx)
Provides insights into how your genes affect response to medicationsPrenatal Screening (Serenity)
Non-invasive screening for genetic risks in fetus during pregnancyImmune Profiling
Comprehensive assessments of immune system health and functionFor more information please call us at 1-800-410-4737, available Monday to Friday, 10 AM to 7 PM ET.About OncoHelix
OncoHelix™ is a Canadian leader in precision diagnostics, specializing in genomic and immunological profiling to support tailored patient care. Headquartered in Calgary, Alberta, our clinically accredited laboratory serves healthcare providers, patients, and industry partners across Canada. Our mission is to make advanced, patient-first diagnostics more accessible and impactful. Learn more www.oncohelix.org About Desjardins Insurance
Desjardins Insurance refers to Desjardins Financial Security Life Assurance Company.
Desjardins®, Desjardins Insurance® and related trademarks are trademarks of the Fédération des caisses Desjardins du Québec, used under licence by Desjardins Financial Security Life Assurance Company.
200 Rue des Commandeurs, Lévis QC G6V 6R2 / 1-866-647-5013
desjardinslifeinsurance.com